Biofrontera Inc. to Showcase Actinic Keratosis Treatments at the Music City Symposium for Cosmetic Advances & Laser Education

Live Demonstration of New RhodoLED XL to be Featured

WOBURN, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today its sponsorship of the 17^th Edition of the Music City Symposium for Cosmetic Advances & Laser Education (SCALE), being held May 11-15, 2022 in Nashville, Tenn. As a Sponsor, Biofrontera will be hosting a booth showcasing its innovative, FDA-approved products and featuring its new RhodoLED XL illumination lamp used in photodynamic therapy (PDT) for treating actinic keratosis (AK). On Saturday, May 14, 2022, Dr. Michael Gold, M.D., a board-certified dermatologist, cosmetic surgeon and founder of Gold Skin Care Center in Nashville, will present a live demonstration of RhodoLED XL during the “Live Lasers and EBDs On Stage” session of the Symposium.

Music City SCALE is considered a premier multidisciplinary meeting for aesthetic medicine, plastic surgery and medical dermatology. This is the first domestic medical conference where the RhodoLED XL lamp will be featured.

“The Biofrontera team looks forward to meeting with dermatologists and healthcare providers, presenting the benefits of Ameluz in combination with BF-RhodoLED and showcasing our new, larger RhodoLED XL PDT lamp among the latest treatments and breakthroughs in medical dermatology and aesthetics. RhodoLED XL, which was approved in combination with Ameluz for the treatment of mild and moderate AK on the scalp, allows for the illumination of a larger skin area, thereby enabling simultaneous treatment of AK lesions that are distant from one another. We remain on track with our plans to launch XL by the end of the year,” stated Hermann Lübbert, Executive Chairman of Biofrontera Inc.

Additionally, Biofrontera recognizes May as Skin Cancer Awareness Month through its support of education-focused initiatives. Biofrontera announced its participation in the Noah Worcester Dermatological Society Conference from May 4-8 in Newport, R.I. as part of its strategic initiative to strengthen medical affairs and education. The Company will also be attending The Skin Cancer Foundation’s Champions for Change Gala 2022 on May 12^th in New York, with proceeds from the fundraiser supporting lifesaving educational campaigns, community programs and research initiatives.